What's new in treating older adults?
Clinical trials in the past few years have yielded findings that are relevant for clinical practice, not just for geriatricians but for all physicians who have elderly patients.
Center for Geriatric Medicine, G10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. rapporb@ccf.org
Barbara
B
Messinger-Rapport
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001281:Atrial Fibrillation; D001562:Benzimidazoles / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D003071:Cognition / Q000502:physiology*; D000069604:Dabigatran; D003693:Delirium; D003704:Dementia / Q000517:prevention & control*; D000069448:Denosumab; D015444:Exercise / Q000502:physiology*; D050723:Fractures, Bone / Q000517:prevention & control*; D005853:Geriatrics / Q000639:trends*; D006801:Humans; D053245:RANK Ligand / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use*; D015091:beta-Alanine / Q000031:analogs & derivatives / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001562:Benzimidazoles; D002800:Cholinesterase Inhibitors; D053245:RANK Ligand; D015091:beta-Alanine; D014807:Vitamin D; D000069448:Denosumab; D000069604:Dabigatran